HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William E Brady Selected Research

Simvastatin (Zocor)

10/2006Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
7/2005LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD.
7/2005Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
2/2005Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
6/2004Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William E Brady Research Topics

Disease

17Neoplasms (Cancer)
10/2019 - 12/2008
10Carcinoma (Carcinomatosis)
01/2022 - 06/2012
7Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 07/2011
4Hypertension (High Blood Pressure)
01/2022 - 07/2002
4Endometrial Neoplasms (Endometrial Cancer)
11/2014 - 03/2009
3Disease Progression
01/2018 - 04/2013
3Fallopian Tube Neoplasms
01/2018 - 03/2010
3Hypercholesterolemia
09/2006 - 06/2004
3Coronary Disease (Coronary Heart Disease)
12/2005 - 02/2005
2Macular Degeneration (Age-Related Maculopathy)
04/2022 - 10/2017
2Atherosclerosis
10/2017 - 01/2016
2Ovarian Epithelial Carcinoma
02/2016 - 10/2012
1Nausea
01/2022
1Fatigue
01/2022
1Exanthema (Rash)
01/2022
1Dysgerminoma
01/2018
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2016
1Multiple Myeloma
04/2016
1Neutropenia
02/2016
1Thrombocytopenia (Thrombopenia)
02/2016
1Sepsis (Septicemia)
02/2016
1Teratoma (Teratoid Tumor)
01/2016
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2016
1Endometrioid Carcinoma
11/2014
1Adenocarcinoma
11/2014
1Carcinosarcoma
06/2014
1Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor)
02/2014
1Carcinogenesis
10/2012
1Sarcoma (Soft Tissue Sarcoma)
10/2012
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2011
1Proteinuria
10/2006

Drug/Important Bio-Agent (IBA)

7PlatinumIBA
01/2022 - 09/2009
6Ezetimibe (Zetia)FDA Link
10/2006 - 06/2004
5Simvastatin (Zocor)FDA LinkGeneric
10/2006 - 06/2004
4Carboplatin (JM8)FDA LinkGeneric
11/2018 - 02/2016
4oxidized low density lipoproteinIBA
09/2006 - 07/2005
3Cisplatin (Platino)FDA LinkGeneric
11/2018 - 03/2009
3CholesterolIBA
11/2017 - 09/2006
31-dodecylpyridoxal (PLD)IBA
11/2017 - 02/2016
3Bevacizumab (Avastin)FDA Link
02/2016 - 04/2013
3LDL CholesterolIBA
09/2006 - 02/2005
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2006 - 12/2005
3Losartan (Cozaar)FDA LinkGeneric
01/2004 - 03/2002
2Paclitaxel (Taxol)FDA LinkGeneric
11/2018 - 07/2011
2liposomal doxorubicin (Doxil)FDA Link
11/2017 - 02/2016
2LuteinIBA
10/2017 - 01/2016
2Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
11/2014 - 11/2011
2Rosuvastatin Calcium (Crestor)FDA Link
10/2006 - 07/2005
2Adenosine Triphosphate (ATP)IBA
09/2006 - 12/2005
2Atorvastatin (Lipitor)FDA Link
07/2005 - 06/2004
2Antihypertensive Agents (Antihypertensives)IBA
07/2002 - 03/2002
1Fatty Acids (Saturated Fatty Acids)IBA
04/2022
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
04/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
1trametinibIBA
01/2022
1cabozantinibIBA
01/2018
1poly(ethylene glycol)-co-poly(ethyleneimine)IBA
11/2017
1Interleukin-12 (IL 12)IBA
11/2017
1ZeaxanthinsIBA
10/2017
1Biomarkers (Surrogate Marker)IBA
10/2017
1Complement Factor H (Factor H)IBA
10/2017
1VTX-2337IBA
01/2017
1Bortezomib (Velcade)FDA Link
01/2017
1Antineoplastic Agents (Antineoplastics)IBA
01/2017
1Proteasome InhibitorsIBA
01/2017
1Lenalidomide (CC 5013)FDA Link
04/2016
1Cytarabine (Cytosar-U)FDA LinkGeneric
04/2016
1veliparibIBA
02/2016
1AntioxidantsIBA
01/2016
1Progestins (Progestagens)IBA
11/2014
1Phenobarbital (Luminal)FDA Link
11/2014
1pazopanibFDA Link
06/2014
1temsirolimusFDA Link
04/2013
1AZD 6244IBA
02/2013
1src-Family KinasesIBA
10/2012
1Dasatinib (BMS 354825)FDA Link
10/2012
1DNA (Deoxyribonucleic Acid)IBA
10/2012
1RacivirIBA
06/2012
1Peptides (Polypeptides)IBA
06/2012
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2012
1acetyl- lysyl- prolyl- seryl- seryl- prolyl- prolyl- glutamyl- glutamic acid amideIBA
06/2012
1Cadherins (E-Cadherin)IBA
11/2011
1TamoxifenFDA LinkGeneric
11/2011
1gamma Catenin (Plakoglobin)IBA
11/2011
1alpha Catenin (alpha E-Catenin)IBA
11/2011
1CateninsIBA
11/2011
1beta CateninIBA
11/2011
1AlbuminsIBA
07/2011
1130-nm albumin-bound paclitaxelIBA
07/2011
1taxaneIBA
07/2011
1Mifepristone (RU 486)FDA Link
03/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2009
1Dihydrotachysterol (AT 10)IBA
10/2006

Therapy/Procedure

9Therapeutics
11/2017 - 02/2005
8Drug Therapy (Chemotherapy)
01/2022 - 07/2002
2Immunotherapy
01/2020 - 01/2017
2Radiotherapy
10/2019 - 11/2018
1Adjuvant Chemotherapy
01/2016
1Hysterectomy
11/2014
1Combination Drug Therapy (Combination Chemotherapy)
09/2009